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Abstract 
Purpose: Although at high risk for contracting HPV, less than half of college women have been 
vaccinated. The purpose of the current study was to examine underlying factors influencing college 
women’s intention to get the HPV vaccine using the Reasoned Action Approach (RAA). Methods: Data 
were collected from two different samples of college women at a large Mid-west university via two 
phases. In Phase 1, a salient-belief elicitation survey based on the RAA was utilized to collect quantitative 
and qualitative data from 43 college women. Phase 1 data were then utilized to create a quantitative 
closed-ended instrument, which was administered to a large sample (n=279) of female college students in 
Phase 2. Results: Results indicated that the perceived consequences of getting the vaccine, such as 
protection against HPV and cervical cancer, were primary determinants influencing intention to get the 
HPV vaccine. Participants perceived healthcare providers and mothers as salient referents influencing 
their vaccination decisions. Attitude towards the act and perceived norm were the major predictors of 
intention to get a vaccine. Conclusions: Results suggest the importance of attitudes and perceived norms 
(especially mothers and healthcare providers) in predicting intention to get the HPV vaccine. Utilizing 
theory-based approaches to design interventions may be beneficial to increase vaccination rates among 
college women. Such interventions could focus on the attitudes and perceived norms of college students’ 
regarding getting the HPV vaccine.  
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Keywords: HPV vaccine. Reasoned Action Approach, health behavior, cervical Cancer, theory based approach, 
Gardasil 
 
Introduction 
 
Human papillomavirus (HPV) is a salient public 
health issue. In the US, approximately 20 
million individuals are infected with HPV, with 
approximately 6.2 million new genital HPV 
infections occurring each year (Cutts et al., 
2007; Centers for Disease Control and 
Prevention [CDC], 2000). Women under the age 
of 25 are at highest risk for HPV infection with 
the prevalence rate of about 27% compared to 
other age groups, ranging from 3 to 12% (Cutts 
et al., 2007; CDC, 2010; Moyer, 2012). HPV is 
the leading cause of cervical cancer and genital 
warts and is considered to be the single most 
important risk factor associated with anogenital 
cancers in women. Cervical cancer is 
responsible for approximately 5% of all cancers 
worldwide and led to nearly 4,000 deaths in the 
US in 2008 (Olsen, Woods, Austin, Luskin, & 
Bauchner, 2005; Moscicki, 2008). The vast 
majority of these deaths are preventable. 
Researchers estimate that approximately 1.5 
million American women currently have an 
HPV-associated disease (i.e. condyloma, 
cervical intraepithelial neoplasia, and cervical 
cancer) which often requires invasive treatment 
procedures; costs associated with such 
treatments are estimated to be $4 billion in the 
US (Insinga, Dasbach, & Elbasha, 2005; 
Moscicki, 2008). The World Health 
Organization (WHO) states that nearly one-third 
of costs associated with cancer could be 
alleviated via early detection and prevention 
mechanisms (World Health Organization 
[WHO], 2009). 
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The HPV vaccine, Gardasil (Merck & Co. Inc.) 
and CervarixTM (GlaxosmithKline), can help 
reduce the spread of HPV as well as alleviate 
costs associated with the disease. Gardasil 
provides protection against four of the most 
common strains of HPV (6, 11, 16, 18) which 
account for approximately 70% of cancer 
causing strains (16, 18) and 90% of the wart 
causing strains (6, 11) (Munoz et al., 2004; 
Lowy & Schiller, 2006). In addition, research 
indicates that the implementation of the HPV 
vaccine could incur significant healthcare 
savings (Goldie et al., 2004; Taira, Neukermans, 
&Sanders, 2004). 
 
Gardasil has been approved by the Food and 
Drug Administration (FDA) for use among 9-26 
year old females since 2006 (Lowy & Schiller, 
2006), and was approved for use among males in 
2009 (CDC, 2010). Research efforts have 
primarily focused on 9-13 year old girls. Young 
girls have been the primary target population for 
vaccination because Gardasil is most effective 
prior to sexual initiation (CDC, 2010), as the 
majority of young people are sexually active by 
their late teens and early 20s (Gray et al., 2008).  
 
Gardasil may be particularly important for 
college students as they tend to engage in higher 
risk sexual behaviors and are at an increased risk 
of contracting sexually transmitted infections 
(STI) compared to the general population (Burak 
& Meyer, 1997). Additionally, less than half of 
female college students reported that they had 
received at least one shot of the vaccine; among 
those even fewer have completed all three shots 
(Jones & Cook, 2008; Licht et al., 2010). 
Furthermore, college students are often in a 
position to make healthcare decisions without 
parental supervision for the first time in a new 
environment, away from home (Wood, Read, 
Mitchell, & Brand, 2004). Therefore, it is 
important to understand why female college 
students decide to go to the doctor to ask (or not 
to ask) for the HPV vaccine. 
 
There is a lack of research addressing factors 
influencing female college students’ decision to 
get vaccinated. Previous HPV vaccination 
research has mainly focused on parental 
awareness and acceptability (Waller, Marlow, & 
Wardle, 2006; Ogilvie et al., 2008; Rosenthal et 
al., 2008) as well as vaccination practices for 
other STIs exclusive of HPV (Liddon et al., 
2005; Liau, Zimet, & Fortenberry, 1998; Mays, 
Sturm, & Zimet, 2004). Although most parents 
and adolescent females had positive attitude 
towards the vaccine (Waller, Marlow, & Wardle, 
2006; Lenselink et al., 2008), little research 
exists which has used a theory-based approach 
to examine the underlying determinants which 
influence women’s intention to get vaccinated. 
In order to address this gap, the current study 
aimed to identify the determinants of female 
college students’ intention to go to their doctor 
to ask for the HPV vaccine using a theory driven 
methodology, the Reasoned Action Approach 
(RAA) as a framework.  
 
Conceptual Framework The RAA can be used 
to identify underlying factors that influence 
intention to engage in various health behaviors. 
The RAA is the most recent formulation of the 
Theory of Reasoned Action, the Theory of 
Planned Behavior, and the Integrated Behavioral 
Model (Fishbein & Ajzen, 2010). The RAA 
proposes that intention is the immediate 
determinant of behavior; that attitude toward the 
act, perceived norm, and self-efficacy combine 
as global components to determine intention. 
The RAA has also been utilized in other studies 
to understand behaviors such as condom use 
(Albarracín, Johnson, Fishbein, & Muellerleile, 
2001), physical activity (Hagger, Chatzisarantis, 
& Biddle, 2002; Downs & Hausenblas, 2005), 
and other health behaviors as well as to develop 
interventions for such behavior (Hardeman et 
al., 2002). 
 
Salient-belief elicitation is the first step of RAA. 
The RAA indicates that there is a belief structure 
underlying the three global components 
(attitude, perceived norm, and perceived 
behavioral control) that influence behavioral 
decisions. However, not all consequences, 
referents, and circumstances are important. 
Instead, this approach emphasizes that 
researchers should identify the salient 
determinants using a salient-belief elicitation. 
Salient consequences, referents and 
circumstances are determined by the most 
frequently mentioned responses from the 
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participants. Conducting a salient-belief 
elicitation before applying the RAA to a new 
population and new behavior helps ensure that 
the instrument is relevant and culturally 
appropriate to the population and context. As 
such, elicitation is a rapid, theory-based, open-
ended, qualitative, formative research technique 
designed to understand the cognitive structure 
underlying people’s decisions to perform a 
behavior (Fishbein & Ajzen, 2010). The present 
study examined the behavior of college female 
students to go to their doctor to ask for the HPV 
vaccine. More specifically, the goals of the study 
were to (1) utilize a salient elicitation technique 
to determine the salient consequences, referents 
and circumstances associated with going to the 
doctor to ask for the HPV vaccine, (2) create a 
theory-based quantitative instrument using RAA 
constructs, and (3) examine the influence of the 
global constructs (i.e., attitude, perceived norm, 
and perceived behavioral control) of the RAA on 
intention to get the HPV vaccine.  
 
Methods 
 
Study Design and Data Collection 
This study was conducted in two phases utilizing 
two waves of data collection. In Phase 1, a 
salient-belief elicitation survey was administered 
to a convenience sample of female college 
students (n = 43); in Phase 2 an RAA-based 
quantitative instrument was developed based on 
the findings from Phase 1 and administered to a 
different sample of female college students (n = 
279). For both phases of the study, participants 
were recruited from a large Mid-western 
university and participation was voluntary. The 
university had a population of approximately 
40,000 students who were mostly white, middle-
class, and between the ages of 18-23. In Phase 1, 
female college students were recruited from an 
undergraduate women’s health course. 
Eligibility requirements included being female 
and between the ages of 18-23 in order to be 
included in the study. Fifty-one questionnaires 
were distributed and 45 were returned. Six 
students did not participate due to ineligibility. 
The final sample included 43 participants; two 
participants had incomplete data and were thus 
removed from the study. As an incentive for 
participation, students had the opportunity to 
enter their name into a pool for a chance to win 
one of four $20 gift cards. In the second phase, 
participants were recruited from undergraduate 
elective health courses (n=14) frequently taken 
by students across a variety of course majors. 
Three hundred and ten questionnaires were 
distributed and 290 were returned. The final 
sample included 279 participants; 11 participants 
were removed due to excessive incomplete data 
that could not be recovered via data replacement 
techniques. In Phase 2, participants were also 
given the opportunity to enter their name into a 
pool for a chance to win a $20 gift cards. All 
study protocols were reviewed and approved by 
Institutional Review Board at the academic 
institution where data collection occurred.  
 
Measures 
The Phase 1 participants filled out a 
questionnaire including open-ended and closed-
ended items. The questionnaire for the Phase 1 
contained 20 items including demographic 
variables, (i.e., age, race, class standing, 
relationship status), elicitation items, and items 
assessing participants’ awareness of the HPV 
vaccine, how participants heard about the HPV 
vaccine, whether or not they had received the 
vaccine, and where they would go to get the 
vaccine. Participants were also asked questions 
regarding their health insurance coverage and 
perceptions of the university health center.  
 
The elicitation items included six open-ended 
questions:(1) “What are the advantages of going 
to the doctor to ask for the HPV vaccine? What 
good things may happen?” (2) “What are the 
disadvantages of going to the doctor to ask for 
the HPV vaccine? What bad things may 
happen?” (3) “Who approves/supports you of 
going to your doctor to ask for the HPV 
vaccine?” (4) “Who doesn’t approve or support 
you of going to your doctor to ask for the HPV 
vaccine?” (5) “What makes it easy for you to go 
to your doctor to ask for the HPV vaccine? What 
circumstances or conditions?” (6) “What makes 
it hard for you to go to your doctor to ask for the 
HPV vaccine? What circumstances or 
conditions?” The results from Phase 1 were used 
to construct the Phase 2 quantitative closed-
ended instrument to examine whether the major 
constructs of RAA predict intention to get the 
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HPV vaccine. The Phase 2 instrument included 
98 questions including demographic variables 
and RAA constructs. Examples of RAA 
constructs include: Intention-“I will go to my 
doctor to ask for HPV vaccine in the next 6 
months (7-point Likert scale: extremely unlikely 
to extremely likely),” attitude towards the act-
“My going to my doctor to ask for HPV vaccine 
in the next 6 months is (7-point Likert scale: 
extremely unpleasant to extremely pleasant),” 
perceived norm-“Most people who are important 
to me think I should go to my doctor to ask for 
HPV vaccine in the next 6 months (7-point 
Likert scale: extremely disagree to extremely 
agree),” and perceived behavioral control- “My 
going to my doctor to ask for HPV vaccine in 
the next 6 months is (7-point Likert scale: not at 
all under my control to completely under my 
control).”  
 
Analytic Methods 
Closed-ended responses from Phase 1 were 
entered in SPSS version 19.0 and the open-
ended responses were entered verbatim into 
Microsoft Word 2007. A content analysis was 
conducted of the six open-ended items to 
identify common categories of responses for 
consequences, referents and circumstances. 
Then the most commonly mentioned, similar 
responses from participants were coded into 
categories for each construct. Like responses 
were combined into individual categories for 
each construct of the RAA. Responses and 
categories were re-organized based on 
discussion among the authors during which they 
came to a final consensus. All three authors 
initially did the content analysis process 
individually, then met and reached consensus on 
the results. After reaching consensus, a 
frequency analysis was conducted to identify the 
percent of participants who mentioned each 
response category. 
 
The closed-ended responses from Phase 2 were 
also entered in SPSS version 19.0. Factor 
analysis and reliability analysis verified the two-
item measure of intention (Cronbach’s α= 0.72), 
a two-item measure of attitude (Cronbach’s α= 
0.82), a three-item measure of perceived norm 
(Cronbach’s α= 0.74), and a four-item measure 
of perceived behavioral control (Cronbach’s α= 
0.69). The results of the principal factors 
extraction with varimax (performed through 
SPSS) extracted four factors (Intention, attitude, 
perceived norm, and perceived behavioral 
control). The factor loadings for each item 
ranged from 0.62 to 0.79; no items were 
eliminated.  Measures for intention and the three 
global components of attitude, norm, and control 
were constructed by calculating the average of 
the items that were confirmed by factor analysis 
and reliability analysis. The dependent variable 
for the regression analysis was the “intention to 
go to your doctor to ask for the HPV vaccine.” It 
is important to mention that the dependent 
variable (Intention) used in regression model 
was an ordinal measure; however Likert 
responses used for these items were treated as 
continuous variables (response options were 
coded from -2 to +2) (Winship & Mare, 1984). 
 
Results 
 
Participant Characteristics 
Participants from both phases were 
predominately white (83.7% for Phase 1; 68.6% 
for Phase 2) similar to the demographics of the 
institution. A majority of participants in Phase 1 
indicated they were freshmen and sophomores 
with an age range of 18-23 and the mean age of 
19.6 (SD = 1.1). Phase 2 participants also ranged 
in age, between 18 and 23 years with a mean of 
20.33 (SD = 1.5), and class standing, with 
23.2% participants indicating they were 
freshmen, 24.7% sophomores, 22.5% juniors 
and 29.7% seniors. 
 
Phase 1 
According to Table 1, a majority (74.4%) of 
participants from Phase 1 had received at least 
one shot of the HPV vaccine. In fact, a majority 
of Phase 1 participants received all three shots 
(53.5%) and 93% of the participants had heard 
of the HPV vaccine. Participants indicated 
hearing about the vaccine primarily via 
television/television commercials (53.5%), their 
healthcare providers (48.9%) and their mothers 
(21%). When asked where they would go to get 
further information about the HPV vaccine, they 
mainly mentioned going to their healthcare 
providers (88.4%), the Internet (39.5%), and the 
university health center (25.6%). 
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Table 1 
 
HPV Vaccination Information and Awareness (n=43) 
Category Label n (%) 
Have you heard about vaccine?  
          Yes 40 (93.0) 
           No         3 (7.0) 
Have you had the vaccine?  
           3 Shots 23 (53.5) 
           2 Shots         3 (7.0) 
           1 Shot 6 (13.9) 
           No 11 (25.6) 
How did you hear about the HPV vaccine? a  
           Television     23 (57.5) 
           Healthcare Provider 21 (52.5) 
           Mother 9 (22.5) 
           School 4 (10.0) 
           Other Media (newspaper, Radio)  4 (10.0) 
           Friend 3 (7.5) 
Where would you get information? a  
           Healthcare Provider 38 (88.4)
           Internet 17 (39.5)
           University Health Center 11 (25.6) 
           Mother         4 (9.3) 
           Friend        3 (7.0) 
Percentages sum to 100% 
a Participants were allowed to give more than one response. 
 
Table 2 presents the results of the perceived 
consequences of going to the doctor to ask for 
the HPV vaccine. Findings indicate that the 
main perceived advantage of getting the vaccine 
was protection: protection from HPV (51.2%) 
and protection from cervical cancer (32.6%). A 
number of the perceived advantages included a 
mention of the healthcare provider-patient 
relationship: the doctor providing accurate 
information, the doctor being honest, and the 
doctor providing a recommendation. For 
example, one participant stated, “I not only get 
the obvious benefits (cancer prevention, wart 
prevention) but I also get my doctor's honest 
opinion about what's on TV about getting the 
vaccine.” 
 
In response to disadvantages of going to the 
doctor to ask for the HPV vaccine, a majority of 
the participants mentioned there were no 
disadvantages, however a few mentioned that 
some doctors may provide biased information 
regarding the vaccine. Other disadvantages 
mentioned by participants included:  having side 
effects, having pain, and costing too much. 
 
As can be seen in Table 3, the participants were 
also asked to identify their perceived referents or 
those who would approve or disapprove of them 
going to the doctor to ask for the HPV vaccine. 
Participants mentioned their family members, 
especially their mothers, as primary perceived 
approving referents as demonstrated by the 
following quote: “My mom approves. She 
always encourages me to prevent disease.” In 
addition, participants mentioned their friends 
and healthcare providers as other perceived 
approving referents. Participants did not 
perceive any referents disapproving the behavior 
of going to the doctor to ask for the HPV 
vaccine, as exemplified by the following quote: 
“No one would disapprove of protecting myself – 
why would anyone disapprove of getting this 
vaccine?” 
 
Table 2 
 
Percent Mentioning Consequences for Going to the 
Doctor to Ask for the HPV Vaccine (n=43) 
Advantages n %  
It will protect me against HPV  22 51.2 
It will protect me against cervical cancer 14 32.6 
Doctor will provide me with accurate 
information 
11 25.6 
Doctor will be honest with me  4 9.3 
I will feel more protected 4 9.3 
Doctor will provide me with a 
recommendation 
3 7.0 
Other advantages 5 11.6 
Disadvantages   
It will have side effects  9 20.9 
It will be painful  4 9.3 
It will cost too much  4 9.3 
I will feel embarrassed  4 9.3 
It will take too much time 3 7.0 
Some doctors will be biased 3 7.0 
Other disadvantages 5 11.6
No disadvantages 10 23.2
Participants were allowed to give more than one response.  
 
Lastly, participants were asked what would 
make it easier or more difficult to go to the 
doctor to ask for the HPV vaccine. As can be 
seen in Table 4, having the knowledge that the 
vaccine will protect participants and improve 
their health was the most frequently mentioned 
circumstance. Consistent with our previous 
findings, characteristics of healthcare providers 
were frequently mentioned under the construct 
of circumstances: having a doctor that will be 
accurate, having a doctor that would make a 
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recommendation and having a doctor that would 
make them feel comfortable as can be seen in 
the following quote: “My doctor and I have a 
good relationship and I feel comfortable asking 
him questions.” 
 
Although the majority of the participants stated 
that there were no barriers to getting the HPV 
vaccine, some of the participants mentioned 
time, cost, and feeling embarrassed as some of 
the perceived barriers.  
 
Table 3 
 
Percent Mentioning Approving Referents for Going to 
the Doctor to Ask for the HPV Vaccine (N=43) 
Category Label n %  
Mother  17 39.5 
Parents  10 23.3 
My family  4 9.3 
My friends 3 7.0 
My doctor 3 7.0 
Everyone 3 7.0 
Myself 10 23.3 
Other referents 3 7.0 
Participants were allowed to give more than one response. 
 
Phase 2 
Using the results of Phase 1, the items for the 
Phase 2 quantitative instrument were developed. 
A standard multiple regression was performed to 
determine whether the intention to get the HPV 
vaccine could be predicted by the global 
constructs of RAA (attitude, perceived norm, 
and perceived behavioral control). As can be 
seen in Table 5, the multiple R was significantly 
different from zero (F(3, 279) = 91.4, p < 0.001) 
with R2 at 0.498 and the adjusted R2 value of 
0.493. All three regression coefficients (i.e. 
attitude, perceived norm, perceived behavior 
control) were significantly different from zero. 
The adjusted R2 indicates that approximately 
49.3% of the variability in intention to get the 
HPV vaccine was predicted by the three global 
components of attitude (β = 0.361, p < 0.01), 
perceived norm (β = 0.412, p < 0.01), and 
perceived behavioral control (β = 0.109, p < 
0.05).  
 
Discussion 
 
Phase 1: Vaccination Awareness  
A majority of the participants in this study had 
heard about the HPV vaccine. Similar to 
previous research (Caron, Kispet, & McGarth, 
2009) most participants had heard about the 
HPV vaccine either through mass media 
(television, television commercials, radio, and 
magazines), their healthcare provider or their 
mothers. In addition, participants reported that 
healthcare providers, the Internet, and the 
university health center were the primary 
sources they would utilize for information about 
the HPV vaccine. Media may raise awareness 
about the vaccine but students seemed to seek 
out other sources (i.e. healthcare providers and 
mothers) to gain additional information.  
 
Table 4 
 
Percent Mentioning Barriers and Facilitators of Going 
to the Doctor to Ask for the HPV Vaccine (N=43) 
Facilitators n %  
Knowing that the vaccine will help me/will 
improve my health 
11 25.6
Having the vaccine being covered by 
insurance 
6 14.0
Having a doctor that is knowledgeable and 
accurate 
6 14.0
Having a doctor makes me feel comfortable 
and trusting 
5 11.6
Having a doctor that recommends the 
vaccine  
4 9.3
Having my mother’s support 4 9.3
Having the vaccine be available and 
convenient to get  
3 7.0
Other facilitators 6 14.0
Barriers  
Taking time 6 14.0
Costing too much 5 11.6
Feeling embarrassed and uncomfortable 4 9.3
Other barriers 6 14.0
No Barriers 15 34.9
Participants were allowed to give more than one response.
 
Construction of Phase 2 Instrument  
 
Behavioral Determinants. This study used a 
theory-based approach to identify salient 
consequences, referents and circumstances in 
Phase 1. The objective was to determine what 
influences female college students’ decision to 
get the vaccine to drive the design of the Phase 2 
instrument. Protection emerged as one of the 
main factors that influenced female college 
students to go to the doctor to ask for the HPV 
vaccine. Improving health and protection from  
cervical cancer and HPV came up as both  
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perceived advantages and facilitators of getting 
the vaccine. Consistent with previous research, 
Phase 1 findings emphasize the importance of 
knowledge regarding protection against cancer 
and HPV as a determinant in predicting intention 
to go to the doctor to get vaccinated (Jones & 
Cook, 2008; Rosenthal, Lewis, Succop, 
Bernstein, & Stanberry, 1999). Based on the 
results of Phase 1, the quantitative instrument 
for Phase 2 included perceived consequences 
items such as being protected and getting 
information about the vaccine.  
 
Table 5 
 
Regression Analysis Summary for Intention to get the 
HPV Vaccine (N=279) 
Variable B SE B Beta T      P 
Attitude 
towards the 
act 
0.696 0.094 0.361 7.418 <0.001 
Perceived 
norm 
0.565 0.068 0.412 8.324 < 0.001 
Perceived 
behavioral 
control 
0.136 0.057 0.109 2.397 0.017 
Note 1: F (3, 279) = 91.4, p < 0.001;  Note 2:  R2 = 0.498; 
the adjusted R2 =0.493.  
 
In Phase 1, a variety of aspects related to the 
patient-provider relationship also emerged as 
salient factors influencing vaccination. Given 
that the role of healthcare providers came up 
under perceived consequences, approving 
referents and circumstances, they seem to play 
an important role in influencing women to get 
the HPV vaccine. Such findings are consistent 
with previous research that explored the role of 
providers’ influence on patients’ decision to get 
vaccinated (Caron, Kispert, & McGarth, 2008; 
Ogilvie et al., 2008; Rosenthal et al., 1999). 
Based on the results of Phase 1, items (such as 
the ones listed) were constructed for the Phase 2 
quantitative instrument: perceived 
consequences-“my going to the doctor to ask for 
the HPV vaccine in the next 6 months will 
provide me with doctor’s recommendation  (7-
point Likert scale: extremely unlikely to 
extremely likely), and ” normative belief- “my 
mother thinks that I should go to my doctor to 
ask for the HPV vaccine in the next 6 months (7-
point Likert scale: extremely unlikely to 
extremely likely).   
 
Conversely, some women mentioned that 
healthcare providers may be biased in terms of 
providing information or recommendations 
about the vaccine as a perceived disadvantage of 
going to the doctor to get the vaccine. This 
demonstrates the importance of the provider-
patient relationship particularly among college 
women as previous research has demonstrated 
(Abbott, Berry, Meredith, 1990). As such, an 
item was included in the Phase 2 quantitative 
instrument to measure the influence of this 
relationship on getting the HPV vaccine: 
perceived power-“having a doctor that makes 
me feel comfortable will make it (7 point Likert 
scale: extremely difficult to extremely easy).” 
 
In addition to healthcare providers, other 
individuals may influence college women’s 
intention to get the HPV vaccine. In Phase 1, 
participants reported parents, other family 
members, friends and significant others as 
approving referents. Like healthcare providers, 
mothers seem to play an important role in terms 
of vaccination as they came up as perceived 
salient referents, perceived salient facilitators 
(mother’s approval), as a source of information 
and how women heard of the vaccine. Such 
findings have been supported by previous 
research (Ogilvie et al., 2008; Olsen et al., 2005; 
Rosenthal et al., 2008). Perhaps mothers 
emerged as one of the most influential people in 
this decision making process because women 
may be more comfortable seeking out their 
maternal parent when getting information, 
advice, or approval for health issues of sensitive 
nature such as sexuality related information. 
Additionally, female college students tend to 
seek their mother’s advice regarding healthcare 
information and inquiries in general as opposed 
to their father (Ogilvie et al., 2008; Rosenthal et 
al., 2008; Waller et al., 2006). The Phase 2 
quantitative instrument included items to 
measure the influence of mothers on the 
intention of college female students: normative 
belief-“my mother thinks that I should go to my 
doctor to ask for the HPV vaccine in the next 6 
months (7-point Likert scale: extremely unlikely 
to extremely likely). ”  
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Although most participants from Phase 1 stated 
that there are no disadvantages, disapproving 
referents and barriers of going to the doctor to 
ask for the HPV vaccine, some participants did 
mention some perceived disadvantages and 
barriers. A few participants mentioned time, 
cost, side effects, pain, and feeling embarrassed 
as perceived disadvantages and barriers 
consistent with previous research (Caron et al., 
2009; Rosenthal et al., 1999). Although cost was 
reported as a perceived disadvantage and barrier, 
having the vaccine covered by insurance was the 
second most common perceived facilitator. The 
Phase 2 quantitative instrument included items 
to measure the influence of cost, health 
insurance, and time on the intention of college 
female students to get the HPV vaccine. 
 
Phase 2: Intention to go to the Doctor to ask 
for the HPV Vaccine 
The results from Phase 2 revealed that all three 
global constructs of the RAA significantly 
predicted intention to get the HPV vaccine 
among college female students. The adjusted R2 
of 0.493, indicated that 49.3% of variability in 
intention to go to the doctor to ask for the HPV 
vaccine could be explained by attitude, 
perceived norm, and perceive behavioral control. 
The size and direction of the standardized 
coefficients suggest that women are more likely 
to intend to get the HPV vaccine if: (1) they 
have a positive attitude towards getting the 
vaccine, (2) they perceive that their salient 
referents would want them to get the HPV 
vaccine, and (3) they perceive that getting the 
vaccine is under their control. Perceived 
behavioral control had the lowest regression 
weight relative to perceived norm and attitude, 
indicating that societal norms and attitudes 
towards getting the vaccine seem to play a more 
important role in the decision making process of 
female college students. Previous studies have 
also suggested the importance of attitude (Kang 
& Moneyham, 2010; Kahn, Rosenthal, Hamann, 
& Bernstein, 2003) and perceived norms (Kahn 
et al., 2003; Conroy et al., 2009) in regard to 
HPV vaccination.  
 
Limitations 
This study was not without limitations, which 
are important to note. First, for Phase 1, women 
were recruited from a women’s health class at a 
large Midwest university, therefore results are 
not generalizable to all women at this university 
nor are they representative of all college women 
in US. Given that this sample was recruited from 
a women’s health class, such women may be 
more apt to engage in health seeking behaviors 
such as vaccination which may account for 
higher rates of vaccination compared to other 
data. In addition, the convenient sample may 
have limited the investigators to learn about a 
wide range of reasons that women do not have a 
positive attitude towards getting the HPV 
vaccine. However, because most women were 
familiar with the HPV vaccine, they were able to 
provide useful data for the construction of the 
Phase 2 instrument. For Phase 2, women were 
recruited from health courses primarily taken as 
electives by students with a wide variety of 
course majors and programs of study at the large 
Mid-west university. Although Phase 2 data are 
not representative of all college women, we 
believe the sample provides a somewhat diverse 
sample of students at that particular university. 
However, both samples were somewhat 
homogenous in regard to race/ethnicity which 
mimics the racial demographics of the 
university.   
 
Implications & Future Research 
Although the current study has the above 
limitations, authors provide suggestions for the 
design of public health interventions and 
conducting of future research. Health educators 
could design interventions in order to change 
women’s attitude and perceived norm towards 
getting the vaccine. For instance, health 
educators can utilize mothers as potential natural 
helpers to provide different types of social 
support (informational, emotional, and 
instrumental). Additionally, public health 
professionals could concentrate on creating 
components of programs that could educate 
students about how to discriminate between 
reliable and unreliable information on the 
Internet and other media.  
 
Although salient consequences, referents, and 
circumstances of female college students to go 
to their doctor to ask for the HPV vaccine were 
identified, more rigorous and extensive research 
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is needed to further confirm these determinants. 
Future studies should utilize the Phase 2 
quantitative instrument to further investigate the 
decision making process of female college 
students as well as males. Further analysis of 
underlying determinants of three global 
constructs of the RAA could be beneficial in 
designing appropriate interventions to increase 
the rate of HPV vaccination among college 
students.  
 
In summary, the theory-based approach used in 
the current study effectively and successfully 
identified perceived consequences, referents, 
and circumstances of college female students’ 
decision to go to their doctor to ask for the HPV 
vaccine. In addition to intrapersonal factors, 
beyond the individual determinants such as the 
influence of family members/friends, healthcare 
providers, insurance policies, and media 
emerged as potential factors that influence 
vaccination decisions. In review of all these 
determinants, it seems that the Social Ecological 
Model (SEM) may be a useful conceptual 
framework for addressing the vaccination 
behavior from both the standpoint of research 
and intervention. This is due to the fact that 
SEM proposes that the health behavior is 
influenced by determinants at multiple levels 
(McLeroy, Bibeau, Steckler, & Glanz, 1988): 
intrapersonal (female college students), 
interpersonal (students’ family, friends, and 
healthcare providers), organizational (university 
and university health center), community, and 
policy (insurance coverage). Incorporating 
multiple levels of determinants may result in the 
development of more specific and effective 
public health interventions.  
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